Ex parte BASHIR-HASHEMI - Page 4




          Appeal No. 1996-0709                                                        
          Application No. 08/228,245                                                  


          negative.                                                                   
               It is well settled that a statement of utility or                      
          enablement in a specification must be accepted by the examiner              
          absent reasons why one skilled in the art would have had                    
          reason to doubt the objective truth of such statement.  In re               
          Langer, 503 F.2d 1380, 1391, 183 USPQ 288, 297 (CCPA 1974); In              
          re Marzocchi,                                                               
          439 F.2d 220, 224, 169 USPQ 367, 370 (CCPA 1971).  Only one of              
          the stated utilities in a specification needs to be credible.               
          See, e.g., Raytheon Co. v. Roper Corp., 724 F.2d 951, 958, 220              
          USPQ 592, 598 (Fed. Cir. 1983).  Moreover, when the claimed                 
          compound belongs to a class of compounds whose members are                  
          recognized to be useful for a particular purpose and it is                  
          within the skill of the art to use the claimed compound for                 
          that purpose, the requirements of both section 101 and 112 are              
          met by a disclosure that the claimed compound is useful for                 
          that purpose.  See, e.g., In re Hitchings, 342 F.2d 80, 89-91,              
          144 USPQ 637, 644-46 (CCPA 1965).  To violate these                         
          requirements, the claimed compound must be “totally incapable               
          of achieving useful results.”  Brooktree Corp. v. Advanced                  


                                          4                                           





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007